The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Biofrontera Inc.(NASDAQ:BFRI) 
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy ...
Website: http://www.biofrontera.us.com
Founded: 1997
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
Biofrontera Days Payable Outstanding ttm (DPO)
Biofrontera Days Receivable Outstanding ttm (DSO)
Biofrontera Days Inventory Outstanding ttm (DIO)
Biofrontera Op Cashflow Per Share ttm
Biofrontera Free Cashflow Per Share ttm
Biofrontera Cash Per Share ttm
Biofrontera P/S ratio ttm
Biofrontera (GAAP) P/E ratio ttm
Biofrontera P/B ratio ttm
No extra charts and metrics for this ticker.